Global $2.8Bn+ Biopsy Devices Market Outlook, 2025: Analysis on Biopsy Needles, Guidance Systems, Biopsy Guns Reagents & Kits, and More -

DUBLIN--()--The "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions, Application, Companies" report has been added to's offering.

Global biopsy device market is anticipated to surpass USD 2.8 Billion by the year end of 2025.

This report captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future.

The main factor that fuel the market growth is minimal invasive surgical procedure which mitigate the complications and side-effects and proliferating the biopsy device. Increasing private funding for cancer research, government expenditure on healthcare across the world, rising technological up-gradation and favorable reimbursement policies will further propel the global biopsy device market in coming future.

As per world cancer report by the end of year 2020 there will be 15 Million new cancer cases. The rising prevalence of cancer disease across the world like breast cancer, lung cancer, prostate cancer etc will drive the market of biopsy devices. These days, people are more health conscious and they are shifting towards minimal invasive technique over conventional technique to ensure complete safety.

Biopsy Needle is One of the Significant Segments in the Global Biopsy Device Market

In this report, we have done comprehensive analysis of different types of Biopsy Device product. By biopsy device product, the market is categorized into 4 parts; Biopsy Needle, Guidance system segment, Biopsy Guns, Reagents and kits in which Biopsy needle is one of the most significant segment in global biopsy device market.

  • Biopsy Needle segmented into two parts; Fine Aspiration Needles and Core Needle.
  • Guidance system is further categorized into three parts; Ultrasound-guided, Stereotactic-guided and Clinically guided.
  • Ultrasound-guided is the major segment among guidance system, where ultrasound is done to identify the abnormalities and then use needle to take sample of tissues from that particular places and this whole process takes 30 minutes.

Besides, this report also discusses about the market of Guidance system, say for instance (Clinically-guided, Stereotactic-guided, Ultrasound-guided) and Reagents & kits system. The above mentioned markets of devices make a great impact on this market due to inclination on minimally invasive surgeries as well as rising prevalence of cancer's like Prostate, Breast and Lungs.

Breast Biopsy is the Largest Application in the Global Biopsy Device Market

In this report, we have fragmented the global biopsy device market on the basis of application into three parts; Breast Biopsy, Lung Biopsy and Prostate Biopsy. The prevalence of breast cancer and prostate cancer across the world is rising at the rapid pace and demand of minimally invasive surgeries among the people is also rising and hence it will further propel the market growth of global biopsy device. In this report, breast biopsy alone dominated the biopsy device market.

Asia-Pacific Will Be One of the Fastest Growing Markets for Biopsy Devices, Globally

In this report, we have done complete insight on regional analysis of global biopsy device market. We have categorized the market into four regional front; North America, Europe, Asia-Pacific and Rest of the world. Asia-Pacific will be one of the fastest growing markets for biopsy device.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summery

4. Global - Biopsy Devices Market

5. Market Share - Global Biopsy Devices

5.1 By Product

5.2 By Application

5.3 By Region

5.4 By End-User

6. By Product - Biopsy Devices Market

6.1 Biopsy Needles

6.1.1 Fine Aspiration Needles

6.1.2 Core Needles

6.2 Guidance Systems

6.2.1 Ultrasound-guided

6.2.2 Stereotactic-guided

6.2.3 Clinically-guided

6.3 Biopsy Guns

6.4 Reagents and kits

6.5 Others (Brushes, Curettes and Punches etc)

7. By Application - Biopsy Devices Market

7.1 Breast Biopsy

7.2 Lung Biopsy

7.3 Prostate Biopsy

7.4 Others

8. By Region - Biopsy Devices Market

8.1 North America

8.2 Europe

8.3 Asia-Pacific

8.4 Rest of World

9. By End-User - Biopsy Devices Market

9.1 Diagnostic Center

9.2 Hospitals

9.3 Others

9.4 C. R. Bard, Inc. - Company Analysis

9.5 Overview

9.6 Merger & Acquisition

9.7 Financial Insight

10. Becton, Dickinson and Company - Company Analysis

10.1 Overview

10.2 Key Developments

10.3 Merger & Acquisition

10.4 Financial Insight

11. B. Braun Melsungen AG - Company Analysis

11.1 Overview

11.2 Key Developments

11.3 Merger & Acquisition

11.4 Financial Insight

12. Cardinal Health, Inc. - Company Analysis

12.1 Overview

12.2 Key Developments

12.3 Merger & Acquisition

12.4 Financial Insight

13. Olympus Corporation - Company Analysis

13.1 Overview

13.2 Key Developments

13.3 Merger & Acquisition

13.4 Financial Insight

14. Boston Scientific Corporation - Company Analysis

14.1 Overview

14.2 Key Developments

14.3 Merger & Acquisition

14.4 Financial Insight

15. Medtronic plc - Company Analysis

15.1 Overview

15.2 Key Developments

15.3 Merger & Acquisition

15.4 Financial Insight

16. Hologic, Inc. - Company Analysis

16.1 Overview

16.2 Key Developments

16.3 Merger & Acquisition

16.4 Financial Insight

17. Growth Drivers

17.1 Inadequate Screening Tests for Particular Cancers

17.2 Demand for Minimally-Invasive Biopsy Technique

17.3 Advancement in Biopsy Techniques

17.3.1 Point A

17.3.2 Point B

17.3.3 Point C

17.3.4 Point D

17.3.5 Point E

18. Challenges

18.1 Breast Biopsy Reimbursement Bundling

18.2 Biopsy Limitations

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900